Understanding Your Laboratory Test: A Patient Guide to Testing, Sample Collection, and Results
This test detects antibodies against Borrelia burgdorferi (Lyme disease bacteria) in cerebrospinal fluid to help diagnose if Lyme disease has affected the nervous system.
{"This test checks for Lyme disease antibodies in the fluid surrounding your brain and spinal cord","A positive result may indicate that Lyme disease has spread to the nervous system","The test uses a specific C6 protein from the Lyme disease bacteria","Your healthcare provider may order this if you have neurological symptoms and potential Lyme disease exposure","Results should be interpreted together with your symptoms and other test results"}
Key facts at a glance
- LOINC
- 38174-9
- Short code
- BBC6CSF
- Synonyms
- B burgdor C6 Ab CSF IA-aCnc
- Category
- chemistry
- Sample
- csf
- Container
- Sterile CSF collection tubes (polypropylene); tube #2 or #4 typically preferred for microbiology and immunology testing to minimize blood contamination
- Units
- N/A
- Ref low
- 0
- Ref high
- 4.9
- Critical range
- — – 10 N/A
- Fasting
- false
- Population
- adult
- Sex
- all
- Age range
- 0–120 years
- Method
- Immunoassay (Enzyme-linked immunosorbent assay detecting C6 peptide antibodies)
- CPT
- 86617
- SNOMED
- 115006000
- Specimen volume
- 0.5-1.0 mL of cerebrospinal fluid
- Stability
- Room temperature: 2 hours; Refrigerated (2-8°C): 24-48 hours; Frozen (-20°C or below): up to 30 days. Avoid repeated freeze-thaw cycles.
- Hemolysis max
- 200
- TAT
- 24–72 hours
- Order
- routine
This test analyzes a sample taken from your body so your healthcare provider can check how well certain organs are working, screen for possible health problems, or monitor a condition you already have. Laboratory testing is a common, safe, and reliable way to gather important information about your overall health.
The Borrelia burgdorferi C6 Antibody test is a specialized blood test that looks for antibodies against the bacteria that cause Lyme disease in your cerebrospinal fluid (CSF). CSF is the clear fluid that surrounds and protects your brain and spinal cord. This test helps doctors determine if Lyme disease has affected your nervous system.
Your doctor may order this test if you have symptoms that need an explanation, as part of a routine checkup, to screen for a condition before symptoms appear, before a procedure, or to see how well a treatment is working over time. It can also be repeated to track changes in your health.
Your healthcare provider may order this test if you have symptoms suggesting neurological Lyme disease, such as severe headaches, facial drooping, numbness, tingling, or muscle weakness. This is particularly likely if you have been in an area where Lyme disease is common or if you remember being bitten by a tick.
The sample is usually collected from a vein in your arm with a small needle, through a quick finger stick, or from a urine specimen, depending on what your provider has ordered. The collection typically takes only a few minutes, and most people can return to their normal activities right afterward.
A healthcare provider will perform a lumbar puncture (spinal tap) to collect a small sample of cerebrospinal fluid. This procedure involves inserting a thin needle into the lower back to withdraw fluid. The sample is then sent to a laboratory for analysis.
Your results show whether your values fall within the normal reference range for this test. A result that is higher or lower than expected may point to a condition that needs further evaluation, but only your healthcare provider can interpret the numbers alongside your symptoms, medical history, and other test findings.
A positive result suggests that your immune system has produced antibodies against the Lyme disease bacteria and that the infection may have reached your nervous system. A negative result does not completely rule out Lyme disease, as antibodies may not be present in the early stages or the test may not detect all cases. Your doctor will interpret the results along with your symptoms, medical history, and other test results.
Reference range
Negative: <5.0 Units (or per laboratory-specific reference); Equivocal: 5.0-9.9 Units; Positive: ≥10.0 Units. Results should be interpreted in conjunction with clinical findings and other diagnostic criteria for neuroborreliosis.N/A
No special patient preparation required. Lumbar puncture should be performed under sterile conditions by qualified personnel. Inform the ordering physician of any anticoagulant therapy, bleeding disorders, or recent spinal procedures prior to collection.
Clinical interpretation
How abnormal results are interpreted and what conditions they suggest.
This test is primarily used to diagnose neurological involvement in Lyme disease, including conditions such as Lyme neuroborreliosis, meningitis, and facial palsy due to Lyme disease. It helps differentiate Lyme disease-related neurological symptoms from other conditions. Early detection and treatment of neurological Lyme disease is important to prevent long-term complications.
Frequently asked questions
Does a positive result mean I definitely have neurological Lyme disease?
Why is this test done on cerebrospinal fluid rather than blood?
How long does it take to get results?
What happens if the test is positive?
Sources
- 1
- 2
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy